Comparison

Fibromodulin F4 226-235 (HLA-A*02:01) European Partner

Item no. EP07972_5
Manufacturer peptides & elephants
Amount 5 mg
Quantity options 1 mg 5 mg
Category
Type Peptides
Specific against Human (Homo sapiens)
Purity 0,95
Sequence YLLDLSYNHL
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias YLLDLSYNHL HLA-A*02:01 Aging Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Available
Manufacturer - Applications
T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Storage Conditions
Store dry at -20°C
C-Terminus
NH2
N-Terminus
H
Counter-Ion
TFA
Description
YLLDLSYNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from tumor-associated antigen Fibromodulin F4 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.
Indication
Aging Cancer
Allele
HLA-A*02:01

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Delivery expected until 10/30/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close